Seon-Wook Hwang
Chief Executive Officer at NOVMETAPHARMA CO., LTD.
Net worth: 5 M $ as of 31/05/2024
Network origin in Seon-Wook Hwang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Seon-Wook Hwang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
| DONGWON F&B CO., LTD. | Food: Major Diversified | Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Corporate Officer/Principal | |
| Pohang University of Science & Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Massachusetts | College/University | Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
| Seoul National University | College/University | Doctorate Degree Doctorate Degree | |
| Inha University | College/University | Graduate Degree | |
| Hanyang University | College/University | Undergraduate Degree | |
| Korea University | College/University | Graduate Degree | |
| Sogang University | College/University | Graduate Degree | |
| Kyungpook National University | College/University | Corporate Officer/Principal | |
| Handong Global University | College/University | Graduate Degree | |
| University of Ulsan | College/University | Corporate Officer/Principal | |
| David Geffen School of Medicine | College/University | Undergraduate Degree | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
| Stritch School of Medicine | College/University | Undergraduate Degree | |
| Reamol Biomedical Consulting Sàrl LLC | Chief Executive Officer |
Statistics
International
| South Korea | 11 |
| United States | 6 |
| Switzerland | 3 |
| France | 2 |
| Belgium | 2 |
Sectoral
| Consumer Services | 16 |
| Health Technology | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 12 |
| Graduate Degree | 8 |
| Undergraduate Degree | 8 |
| Corporate Officer/Principal | 7 |
| Doctorate Degree | 6 |
Most connected contacts
| Insiders | |
|---|---|
| Johan Auwerx | 6 |
| Sang-Joon Kim | 4 |
| Hoi-Yoon Jung | 4 |
| Mun-Jin Song | 3 |
| Chun-Su Lee | 3 |
| Gi-Eop Lee | 3 |
| In-Gyu Lee | 3 |
| Jong-Man Seol | 3 |
| Gyung-Tae Kim | 3 |
| Heon-Jong Lee | 2 |
| Mun-Gi Song | 1 |
| Jae-Ryong Lee | 1 |
- Stock Market
- Insiders
- Seon-Wook Hwang
- Company connections
